<article>Hong Kong-based private equity firm <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=China+Broadband+Capital" target="_blank">China Broadband Capital</a> has led a series B round in oncology-focussed big data firm <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=LinkDoc+Technology+Ltd" target="_blank">LinkDoc Technology Ltd</a>.
Ally Bridge Group, Cenova Ventures, and NEA also participated in the round.</article>

Hong Kong-based private equity firm <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=China+Broadband+Capital" target="_blank">China Broadband Capital</a> has led a series B round in oncology-focussed big data firm <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=LinkDoc+Technology+Ltd" target="_blank">LinkDoc Technology Ltd</a>.
Ally Bridge Group, Cenova Ventures, and NEA also participated in the round.
This is China Broadband Capital&#8217;s third investment this year. It previously led a $100 million round in <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=Qiniu" target="_blank">Qiniu</a>, with Harvest Global Investments and Telstra Ventures as co-investors, and $10 million round in <a style="color: #000080;" href="http://www.dealstreetasia.com/?s=Ping%2B%2B" target="_blank">Ping++</a> with Linear Venture, Sequoia Capital China and Shengjing Technology.
Beijing-based LinkDoc works with big data related to oncology, the study and treatment of cancerous tumors. Over the years, cases of cancer in China have exploded. About four million people might be suffering from some form of cancer by 2020, according to estimates by the World Cancer Society.
&#8220;Big data-driven personalized medicine has become an irreversible trend in global healthcare,&#8221; said Frank Yu, founder of Ally Bridge Group, in a statement.
LinkDoc focusses on certain forms of cancer. It has a presence in more than 200 oncology hospitals in china. It has a built a huge database of patients&#8217; medical records, which are then used for analytics that can help doctors and aid in drug development.
Oncology-related organisations have raised funding in recent times as such cases are projected to grow rapidly. That would mean the need for better drugs and innovations in treatment.
In February, drug development startup Impact Therapeutics <a style="color: #000080;" href="http://www.dealstreetasia.com/stories/31775-31775/" target="_blank">raised $10 million</a> from China Summit Capital, Guangzhou Yuexiu Industrial Investment Fund, Sungent Bioventure and Haibang Ventures. Last week, CITIC Private Equity Funds Management <a style="color: #000080;" href="http://www.dealstreetasia.com/stories/35988-35988/" target="_blank">made a strategic investment</a> in Beijing New Journey Cancer Hospital.
Founded in 2006, China Broadband Capital has become one of the most influential investors in telecom, Internet, broadband, media and technology sectors in China.
Also read:
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/chinese-hunt-for-deals-helps-offset-weaker-first-quarter-for-ma-36346/" target="_blank">China’s shopping spree helps offset weak Q1 for global M&amp;As</a>
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/china-dealbook-legend-capital-puts-30m-in-haizi-cybernaut-launches-ma-fund-32875/" target="_blank">Legend Capital leads $30m round in Haizi, Cybernaut launches $9b M&amp;A fund</a>
<a style="color: #ff0000;" href="http://www.dealstreetasia.com/stories/35988-35988/" target="_blank">CITIC PE invests in Beijing New Journey Cancer Hospital</a>

Data firm LinkDoc raises Series B led by China Broadband Capital

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief

Data firm LinkDoc raises Series B led by China Broadband Capital

Create an account to continue reading this premium story for free

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief